PITPNC1 induces radioresistance in rectal cancer by repressing CD8+ T-cell immunity
Feb. 1, 2024
Radiation therapy resistance (radioresistance) is a key contributor to the failure of rectal cancer treatment, with immunosuppression playing a significant role here.